Barclays’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.7K Sell
36,436
-51,228
-58% -$102K ﹤0.01% 4372
2025
Q4
$215K Buy
87,664
+6,077
+7% +$26.4K ﹤0.01% 4272
2025
Q3
$547K Sell
81,587
-18,704
-19% -$122K ﹤0.01% 3754
2025
Q2
$590K Buy
100,291
+47,228
+89% +$308K ﹤0.01% 3665
2025
Q1
$445K Sell
53,063
-24,222
-31% -$218K ﹤0.01% 3604
2024
Q4
$539K Sell
77,285
-2,411
-3% -$16.1K ﹤0.01% 3773
2024
Q3
$460K Buy
79,696
+62,073
+352% +$399K ﹤0.01% 3834
2024
Q2
$117K Sell
17,623
-23,423
-57% -$189K ﹤0.01% 3834
2024
Q1
$536K Sell
41,046
-30,246
-42% -$403K ﹤0.01% 3543
2023
Q4
$918K Buy
71,292
+54,952
+336% +$555K ﹤0.01% 3496
2023
Q3
$199K Sell
16,340
-2,934
-15% -$53.7K ﹤0.01% 3303
2023
Q2
$475K Buy
19,274
+653
+4% +$16.9K ﹤0.01% 2781
2023
Q1
$479K Buy
18,621
+9,666
+108% +$227K ﹤0.01% 3297
2022
Q4
$210K Buy
8,955
+7,541
+533% +$174K ﹤0.01% 3811
2022
Q3
$32K Sell
1,414
-3,654
-72% -$70.7K ﹤0.01% 3920
2022
Q2
$73K Sell
5,068
-3,282
-39% -$55.3K ﹤0.01% 3902
2022
Q1
$157K Buy
+8,350
New +$162K ﹤0.01% 3567

Other funds holding TMCI